Fricke D.
46
Coauthors
5
Documentos
Volumen de publicaciones por año
Cargando gráfico
Año de publicación | Num. Publicaciones |
---|---|
2017 | 1 |
2018 | 2 |
2019 | 1 |
2022 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
Área de conocimiento | Num. Publicaciones |
---|---|
Fisiología | 5 |
Diabetes | 1 |
Neuropsicología | 1 |
Biomedicina | 1 |
Psicopatología | 1 |
Biología del desarrollo | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
Área temática | Num. Publicaciones |
---|---|
Fisiología humana | 4 |
Enfermedades | 4 |
Farmacología y terapéutica | 3 |
Bioquímica | 1 |
Psicología diferencial y del desarrollo | 1 |
Temas específicos de historia natural de los animales | 1 |
Ginecología, obstetricia, pediatría, geriatría | 1 |
Principales fuentes de datos
Origen | Num. Publicaciones |
---|---|
Scopus | 5 |
Google Scholar | 0 |
RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
Coautor | Num. Publicaciones |
---|---|
David Edward Komatsu | 5 |
Thanos P.K. | 5 |
Hadjiargyrou M. | 5 |
Martin C. | 3 |
Robison L.S. | 2 |
Popoola D. | 2 |
Vijayashanthar A. | 2 |
Hamilton J. | 1 |
Yao R. | 1 |
Blum K. | 1 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Methylphenidate regulation of osteoclasts in a dose- A nd sex-dependent manner adversely affects skeletal mechanical integrity
ArticleAbstract: Methylphenidate (MP) is the most prescribed psychostimulant for ADHD patients, with clinically demonPalabras claves:Autores:Chernoff E., David Edward Komatsu, Fricke D., Hadjiargyrou M., Robison L.S., Thanos P.K., Uddin S.M.Z.Fuentes:scopusRecovery from behavior and developmental effects of chronic oral methylphenidate following an abstinence period
ArticleAbstract: Chronic oral methylphenidate (MP) exposure in rats is associated with numerous developmental and behPalabras claves:anxiety, Attention Deficit Hyperactivity Disorder, methylphenidate, Psychostimulant, ritalin, SensitizationAutores:David Edward Komatsu, Fricke D., Hadjiargyrou M., Koutsomitis D., Lowinger C., Martin C., Popoola D., Thanos P.K., Vijayashanthar A.Fuentes:scopusChronic treatment and abstinence from methylphenidate exposure dose-dependently changes glucose metabolism in the rat brain
ArticleAbstract: Methylphenidate (MP) is extensively prescribed for attention deficit hyperactivity disorder (ADHD).Palabras claves:Brain Glucose Metabolism, FDG, imaging, methylphenidate, PetAutores:Blum K., David Edward Komatsu, Delis F., Fricke D., Hadjiargyrou M., Hamilton J., Martin C., Richer K., Sajjad M., Thanos P.K., Yao R.Fuentes:scopusWeekday-only chronic oral methylphenidate self-administration in male rats: Reversibility of the behavioral and physiological effects
ArticleAbstract: Methylphenidate (MP) is a commonly prescribed psychostimulant for Attention Deficit Hyperactivity DiPalabras claves:anxiety, Attention Deficit Hyperactivity Disorder, Depression, methylphenidate, Psychostimulant, ritalin, SOCIAL BEHAVIORAutores:Carias E., David Edward Komatsu, Fricke D., Hadjiargyrou M., Kalinowski L., Martin C., Popoola D., Smith L., Somanesan R., Thanos P.K., Vijayashanthar A.Fuentes:scopusSex differences in the physiological and behavioral effects of chronic oral methylphenidate treatment in rats
ArticleAbstract: Methylphenidate (MP) is a psychostimulant prescribed for Attention Deficit Hyperactivity Disorder. PPalabras claves:Attention Deficit Hyperactivity Disorder, methylphenidate, Psychostimulant, ritalin, Sensitization, Sex differencesAutores:David Edward Komatsu, Fricke D., Gandhi J., Hadjiargyrou M., Lam C., Lee J., Mauceri A., Miao E., Michaelos M., Paeng S., Robison L.S., Thanos P.K., Vitale M.Fuentes:scopus